Nephros, Inc. (NEPH)
2.94
+0.12
(+4.07%)
USD |
NASDAQ |
Mar 31, 16:00
2.94
0.00 (0.00%)
After-Hours: 16:48
Nephros EPS Diluted (Quarterly) : 0.0055 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cerus Corp. | -0.0114 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.062M |
| Revenue (Quarterly) | 4.729M |
| Total Expenses (Quarterly) | 4.667M |
| Enterprise Value | 25.73M |
| Gross Profit Margin (Quarterly) | 57.71% |
| Profit Margin (Quarterly) | 1.31% |
| Earnings Yield | 3.76% |
| Operating Earnings Yield | 3.57% |
| Normalized Earnings Yield | 3.758 |